T-8 readiness snapshot vs the 47-company peer cohort of recent S-1 filers. Prepared for the CFO and audit committee.
At T-8 months from the target Q1 2027 S-1, Helios Robotics' SOX 404 readiness program is behind peer median on 4 of 6 indicators. The gap is concentrated in Big 4 walkthrough coverage and open significant deficiencies. The cohort suggests a peer-validated path to close the gap.
Helios is running with a compressed testing window (4 months projected vs 7 month peer median) and uneven Big 4 alignment (40% walkthrough coverage vs 65% peer median). These two indicators together account for substantially all of the readiness score gap. Helios is on par with peers on program setup, control design, and entity-level governance.
How each metric ranks against the peer cohort, with the relevant percentile and gap commentary.
| Metric | Helios | Peer median | Percentile | Status |
|---|---|---|---|---|
| Big 4 walkthrough coverage % of planned walkthroughs completed |
40% | 65% | p15 | BEHIND |
| Open significant deficiencies Higher is worse |
3 | 1 | p85 | BEHIND |
| Months of testing history at projected filing | 4 mo | 7 mo | p12 | BEHIND |
| Pre-IPO readiness score Composite across 6 sub-dimensions |
62 | 71 | p28 | BEHIND |
| Controls in scope | 175 | 158 | p62 | WITHIN RANGE |
| Months to target filing | 8 | — | — | CONTEXTUAL |
The 62-point composite breaks down as:
| Sub-dimension | Helios | Peer median | Percentile | Weight |
|---|---|---|---|---|
| Program setup | 75 | 78 | p42 | 10% |
| Control design | 78 | 76 | p58 | 20% |
| Testing maturity | 48 | 70 | p18 | 20% |
| Evidence quality | 62 | 68 | p35 | 15% |
| Big 4 alignment | 50 | 74 | p14 | 20% |
| Finding remediation | 55 | 70 | p22 | 15% |
Testing maturity and Big 4 alignment are the two weakest sub-scores. Closing those two alone is projected to lift the composite to ~74 within a quarter.
47 peer companies in similar gap profiles closed the gap via four observable plays. Helios's recommended ask combines two of them.
| Play | Median cost | Peers chose | Closes which gap |
|---|---|---|---|
| Big 4 catch-up engagement 12-week scoped sprint with the existing audit firm |
$450K | 24 of 47 | Walkthrough coverage · Big 4 alignment |
| Headcount addition 2 SOX analysts (loaded) |
$360K | 15 of 47 | Testing maturity · Deficiency cycle time |
| Filing delay Push target by one quarter |
— | 11 of 47 | All gaps (mechanically buys more T) |
| Control rationalization Drop 10-15 should-have controls |
— | 8 of 47 | Testing throughput (compatible with other plays) |
Peers may have chosen >1 play; counts are not mutually exclusive.
Outcomes for peers in similar gap profiles who chose none of these plays: 3 of 47 received a qualified opinion on first-year SOX. 7 of 47 received management letter comments without a qualified opinion. The remaining peers filed cleanly but with elevated audit scrutiny in year 2.
| Item | Cost | Decision deadline | Projected impact |
|---|---|---|---|
| Deloitte 12-week catch-up engagement | $450K | 4 weeks | Walkthrough coverage 40% → ~80% |
| Dedicated remediation lead (6-mo contractor) | $180K | 6 weeks | Deficiency cycle 74 → ~42 days |
| Total ask | $630K | — | Composite readiness 62 → ~74 by T-4 |
Source data, cohort construction, sample size notes, and limits of the comparison.
Auditborb Benchmark. Cohort: 47 pre-IPO companies that filed S-1 between January 2024 and April 2025. Selection: U.S. public-company S-1 filings only; SPACs, direct listings, and confidential filings excluded. Peer programs are tracked from tenant-consented operational telemetry, supplemented by public S-1 disclosures, prospectuses, and post-IPO audit committee minutes where available.
Filters by industry vertical (6 categories), revenue band (3 bands), and Big 4 auditor (4 firms) produce sub-cohort cells with sample sizes between N=1 and N=24. Sample size is surfaced inline at every chart. Sub-cohorts of N<10 are flagged as small-sample — point comparisons (median, single percentile) are reported but distribution shapes are not.
For Helios's filtered slice (industrials / $500M-1B / Deloitte): N=5 peers, small sample. The headline comparisons in this memo use the full N=47 cohort. The filtered N=5 comparison directionally matches but is not statistically meaningful.
Percentile ranks are computed against the cohort distribution at the same T-stage. For metrics where higher is worse (open deficiencies), the rank is inverted — a peer at p85 has more open deficiencies than 85% of the cohort.